Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcuity RM Group plc Regulatory News (ACRM)

Share Price Information for Acuity RM Group plc (ACRM)

Share Price is delayed by 15 minutes
Get Live Data
0.75    -0.175 (-18.92%)
Bid:
0.70
Ask:
0.80
Spread: 0.10 (14.286%)
Market Cap: £1.83m
ACRM Live PriceLast checked at - London Stock Exchange

Intraday Acuity RM Group plc Share Chart

Changes in share options

7 Feb 2025 07:00

Acuity RM Group Plc - Changes in share options

Acuity RM Group Plc - Changes in share options

PR Newswire

LONDON, United Kingdom, February 07

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

7 February 2025

 

Acuity RM Group plc

("Acuity" or the "Company")

Changes in Share Options

Acuity (AIM:ACRM), the software group, announces that, when Kerry Chambers left the Company her options lapsed. On 6 February 2025, share options were granted to David Rajakovich, the new Chief Executive. These options are identical in all respects to the lapsed options save as to date of grant and expiry date as detailed below: 

 

Name

Position

Options granted

Total number of options held

David Rajakovich

Chief Executive

2,251,922

2,251,922

 

The options have been granted under the Company's approved Enterprise Management Incentive share option scheme (the "EMI Scheme") and have an exercise price of 3.75 pence per share, the closing mid-market price of the shares, as derived from the AIM Appendix to the London Stock Exchange Daily Official List for 25 June 2024, (being the then market price as defined under the rules of the EMI Scheme), which compares with 6 February 2025 closing mid-market price of 1.85 pence per share.  The options are exercisable in whole or in part at any time in the next five years conditional on the market price (under the rules of the EMI Scheme) of the Company's shares reaching double the exercise price for a period of at least five consecutive trading days.

  

The total number of options granted and outstanding under the EMI Scheme is 7,131,088, representing approximately 4.75 per cent of the Company's current issued share capital. In addition, there are 1,600,000 unapproved share options. Accordingly, the total number of options that are outstanding is 8,731,088, representing approximately 5.82 per cent of the current issued share capital.

Enquiries:

For further information: 

Acuity RM Group plc

020 3582 0566

Angus Forrest, Chairman

https://www.acuityrmgroup.com

 

Zeus (NOMAD & Joint Broker)

https://www.zeuscapital.co.uk

Mike Coe / James Bavister

020 3829 5000

 

Peterhouse Capital Limited (Joint Broker)

020 7469 0936

Lucy Williams / Duncan Vasey

 

Clear Capital Markets Limited (Joint Broker)Bob Roberts

020 3869 6080

 

Note to Editors

Acuity RM Group plc

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning software platform, STREAM®, which collects and analyses data about organisations to improve business decisions and management, is currently used by around 70 organisations in markets including government, utilities, defence, broadcasting, manufacturing and healthcare.

The Company is focused on delivering long term, sustainable growth in shareholder value from organic growth and complementary acquisitions.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Rajakovich

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Acuity RM Group plc

b)

 

LEI

 

 

213800JHJFKALDJA5X97 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Share Options over Ordinary shares of 0.1p each

 

 

GB00BR0WHY71 

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

3.75p

2,251,922

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 n/a

 

 

 

e)

 

Date of the transaction

 

6 February 2025

f)

 

Place of the transaction

 

Outside of a trading venue

 

 



12
Date   Source Headline
20th Jan 20257:00 amPRNHolding(s) in Company
13th Dec 202412:38 pmPRNBoard Changes
26th Nov 20247:00 amPRNContract
19th Nov 20247:00 amPRNAcquisition
4th Nov 20247:00 amPRNDirectorate Change
7th Oct 20247:00 amPRNHolding(s) in Company
18th Sep 20247:00 amPRNInvestor Presentation via Investor Meet Company
16th Sep 20247:00 amPRNHalf-year Report
5th Aug 20242:34 pmPRNDirector/PDMR Shareholding
15th Jul 20247:05 amPRNChange of Adviser
10th Jul 20242:17 pmPRNNotice of AGM Result
10th Jul 20247:00 amPRNAGM Statement
26th Jun 20244:27 pmRNSGrant of Options
17th Jun 20243:15 pmRNSCorrection: Result of Placing and Subscription
17th Jun 20249:36 amRNSResult of Placing and Subscription
17th Jun 20247:00 amRNSProposed Placing and Subscription
14th Jun 20247:07 amPRNDirectorate Change
14th Jun 20247:00 amPRNAnnual Financial Report
13th Jun 20247:34 amPRNAnnual Financial Report
10th Jun 20247:00 amRNSNew professional services agreement and order
13th May 20247:00 amPRNContract
8th May 20247:00 amRNSNew partnership and order
22nd Apr 20247:00 amRNSNew product launch
11th Mar 202410:33 amPRNHolding(s) in Company
25th Jan 20247:00 amPRNContract win
17th Jan 20247:00 amPRNYear end Update
18th Dec 20237:00 amRNSNew Contract win
12th Dec 20237:00 amPRNContract and Corporate Update
10th Nov 20237:00 amPRNHolding(s) in Company
31st Oct 20237:00 amRNSNew Contract win
10th Oct 20237:00 amRNSNew Contract win
9th Oct 20233:56 pmPRNIssue of Equity
6th Oct 20237:00 amPRNDirectorate Change
28th Sep 20238:04 amPRNHalf-year Report
28th Sep 20237:57 amPRNFinal Results
5th Sep 20237:00 amRNSNew Contract win
20th Jul 20237:00 amPRNContract win
4th Jul 20237:00 amPRNDirectorate Changes
27th Jun 202311:15 amPRNResult of AGM
23rd Jun 20237:00 amPRNDirectorate Change
9th Jun 20237:00 amRNSContract win
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.